Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02011607
Other study ID # 812903
Secondary ID
Status Terminated
Phase
First received
Last updated
Start date January 2013
Est. completion date December 31, 2018

Study information

Verified date February 2024
Source University of Pennsylvania
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

We propose to collect the data of vital signs and anesthesia medications administered in a subcategory of patients coming for anesthesia for upper GI endoscopy. This data will be analyzed to see any relation between the preoperative risk factors, procedure, type of anesthesia and the airway intervention. The adverse events that will be automatically recorded and later analyzed will be number of apnea episodes (described as no respiration for at least 30 seconds) duration of each apnea, number and duration of each desaturation event (oxygen saturation as measured by the pulse oximeter). A pulse oximeter saturation of less than 93 percent and lasting 30 seconds will be considered as a desaturation event. The airway interventions that will be recorded will be anything other than considered being routine. This includes LMA insertion, endotracheal intubation and the need to withdraw gastroscope to facilitate face mask ventilation. We also propose to monitor their awareness/depth of sedation/depth of anesthesia levels. This will be done using a monitor that analyses brain waves and gives an idea of sleep (anesthesia) depth. We can then see any correlation between any unwanted events and the sleep depth.


Recruitment information / eligibility

Status Terminated
Enrollment 224
Est. completion date December 31, 2018
Est. primary completion date December 31, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria: - All the patients considered as high risk (see above) or undergoing an advanced upper GI procedure (see above) will be included. This is the prospective analysis of the data that is collected and stored in the monitors. We will be using the massimo Pulse oximeter ,masimo acoustic respiratory monitor and Masimo SED line Brain function monitors that allows electronic storage and retrieval of information. - Postprocedure analysis of the data will not influence the patient care. Exclusion Criteria: - Any patient who cannot give a valid consent will be excluded - Children - Pregnant women - Fetuses and/or Neonates - Prisoners

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States Hospital of the University of pennsylvania Philadelphia Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
University of Pennsylvania

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary incidence of adverse events during the procedure
See also
  Status Clinical Trial Phase
Recruiting NCT05390125 - Effectiveness of a Proficiency-based Progression Communication Training Programme
Completed NCT04012320 - Efficacy and Safety on the Use of Bisphosphonates in Paediatrics
Completed NCT02268331 - Comparison of Active vs. Passive Surveillance to Collect Adverse Events N/A
Completed NCT00244673 - Randomized Study of Not Giving Diphteria-tetanus-pertussis Vaccination With or After Measles Vaccination Phase 4
Recruiting NCT05038527 - ABM/P-15 Bone Graft vs Traditional Bone Graft in Adult Spinal Deformity Surgery N/A
Completed NCT01291667 - Study for HER2-Overexpressed MBC Patients Treated by Cipterbin® Plus vinorelbinE Phase 3
Completed NCT00681395 - Study to Compare the Bioavailability of ABT-335 and Rosuvastatin From ABT-143 Relative to That From the Co-administration of ABT-335 and Rosuvastatin Calcium Phase 1
Completed NCT05359666 - Retrospective Independent Safety Review of Closed Irrisept Study N/A
Recruiting NCT05311579 - Niraparib Plus Anlotinib for Recurrent Ovarian Cancer Phase 2
Recruiting NCT05311566 - PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer Phase 2
Recruiting NCT05310344 - Albumin-bound Paclitaxel and Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer Phase 2
Completed NCT05815615 - Plasmapheresis: a Multi-modal Approach N/A
Completed NCT02130570 - Relative Patient Benefits of a Hospital-PCMH Collaboration Within an ACO to Improve Care Transitions N/A
Recruiting NCT05804188 - CRICKET: Critical Events in Anaesthetised Kids Undergoing Tracheal Intubation
Not yet recruiting NCT06117176 - Prospective Assessment Project of AirwaY Management-related Incidents in Adult Anaesthesia Care PAPAYA III
Recruiting NCT02725073 - Photodynamic Therapy in Locally Advanced Hilar Cholangiocarcinoma Phase 2
Completed NCT02928705 - Quality of Telemedically Guided Prehospital Analgesia N/A
Withdrawn NCT01128127 - Strategies for Improving Proton Pump Inhibitors (PPIs) Prescription Associated to Non-steroidal Anti-inflammatory Drugs (NSAIDs) N/A
Completed NCT02310815 - ReSure Sealant Post Approval Study N/A
Recruiting NCT05709392 - Preterm DElayed Cord Clamping and Early Skin-to-Skin Contact: PreDECESS N/A